Published Online: Monday, May 1, 2006

The federal courts have pulled the plug on another prominent importer of Canadian prescription drugs, ruling that Canada Care Drugs Inc should be permanently enjoined from shipping pharmaceuticals to patients in the United States. The court's action was taken in the wake of an undercover investigation by FDA officials seeking to prevent cross-border sales of prescription medicines.

The kinds of products purchased undercover by the FDA from Canada Care "are often shipped with inadequate instructions for use or in inappropriate quantities that facilitate use of the product without the input of a physician that is needed to assure that the product is used in a manner to prevent serious, and even fatal, consequences," the agency official said.

Latest Articles
In case you got caught up in the Thanksgiving holiday rush, here are the top trending stories you may have missed in November:
Bryan Ziegler, PharmD, executive director of Kennedy Pharmacy Innovation Center, provides some resources for community pharmacists to use when implementing new collaborative services with primary care providers.
James Schiffer, RPh, associate at Allegaert Berger & Vogel LLC, discusses some tips for pharmacists who are facing a Drug Enforcement Administration audit.
Carlos Aquino, founder and president of PharmaDiversion LLC, talks about the importance of the Drug Enforcement Administration's (DEA) diversion website.
Latest Issues